IRIS-Coroflex NEO Cohort

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-01-09

Study Completion Date

2030-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to evaluate the effectiveness and safety of Coroflex ISAR NEO stents in comparison to other drug-eluting stents (DES) in real-world practice.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

IRIS-BioFreedom Cohort in the IRIS-DES Registry

NCT03190057

Coronary Stenosis

TERMINATED

IRIS- DESyne X2 in the IRIS-DES Registry

NCT03588481

Coronary Stenosis Coronary Occlusion Coronary Disease

RECRUITING

STabilization of Atheroma by Lipid-reducing Effect of Drug-Coated Balloon (STABLE-DCB)

NCT05438121

Coronary Artery Disease Atherosclerotic Plaque De Novo Stenosis

RECRUITING

IRIS Ultimaster Cohort in the IRIS-DES Registry

NCT02719106

Coronary Artery Disease

COMPLETED

IntravasCular Imaging-Guided Versus AngiogRaphy-GUided Drug-Eluting Stent Implantation for Fermoropopliteal Artery Disease

NCT05805280

Femoropopliteal Disease

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Stenosis Coronary Artery Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Coroflex ISAR NEO

Patients receiving percutaneous coronary intervention with Coroflex ISAR NEO stents

Coroflex ISAR NEO stent

Intervention Type DEVICE

Percutaneous coronary intervention with Coroflex ISAR NEO stent

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Coroflex ISAR NEO stent

Percutaneous coronary intervention with Coroflex ISAR NEO stent

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients ≥ 19 years old
2. Patients receiving Coroflex ISAR NEO stents.
3. The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.

Exclusion Criteria

1. Patients with a mixture of other DESs
2. Terminal illness with life expectancy \<1 year.
3. Patients with cardiogenic shock

Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Seung-Jung Park

professor

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Asan Medical Center

Seoul, Songpa-gu, South Korea

Site Status RECRUITING